A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Incepta Pharmaceuticals Ltd
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Novartis
Merck Sharp & Dohme LLC